Literature DB >> 3080769

Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness.

D R Rubinow, R M Post, P W Gold, T W Uhde.   

Abstract

Carbamazepine, a tricyclic anticonvulsant effective in the treatment of major affective disorder, has been observed to induce cortisol non-suppression following dexamethasone administration. The mechanism of this effect has not been clearly established. In this study, the authors report carbamazepine-induced elevations of mean urinary free cortisol in patients with affective illness. The theoretical and practical implications of these findings are discussed.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3080769     DOI： 10.1007/bf00310525

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  12 in total

1.  PHYSIOLOGY OF URINARY CORTISOL EXCRETION.

Authors:  W R BEISEL; J J COS; R HORTON; P Y CHAO; P H FORSHAM
Journal:  J Clin Endocrinol Metab       Date:  1964-09       Impact factor: 5.958

2.  Mechanism for interference of carbamazepine in Porter-Silber reaction for determination of urinary 17-hydroxycorticosteroids.

Authors:  K Arisue; Y Katayama; Z Ogawa; C Hayashi; M Miyata; K Shimada; T Nambara
Journal:  Chem Pharm Bull (Tokyo)       Date:  1976-12       Impact factor: 1.645

3.  Urinary free cortisol excretion in depression.

Authors:  B J Carroll; G C Curtis; B M Davies; J Mendels; A A Sugerman
Journal:  Psychol Med       Date:  1976-02       Impact factor: 7.723

4.  Carbamazepine and urinary 17-hydroxycorticosteroids.

Authors:  I S Salti; J A Zeid
Journal:  Clin Chem       Date:  1979-03       Impact factor: 8.327

5.  Effects of carbamazepine on cerebrospinal fluid somatostatin.

Authors:  D R Rubinow; R M Post; P W Gold; J C Ballenger; S Reichlin
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Interference by carbamazepine with the dexamethasone suppression test.

Authors:  M R Privitera; J F Greden; R W Gardner; J C Ritchie; B J Carroll
Journal:  Biol Psychiatry       Date:  1982-05       Impact factor: 13.382

7.  Neuroendocrine and peptide effects of carbamazepine: clinical and mechanistic implications.

Authors:  D R Rubinow; R M Post; P W Gold; T W Uhde
Journal:  Psychopharmacol Bull       Date:  1984

8.  Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.

Authors:  T A Moreland; B K Park; G W Rylance
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

9.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

10.  CSF somatostatin in affective illness.

Authors:  D R Rubinow; P W Gold; R M Post; J C Ballenger; R Cowdry; J Bollinger; S Reichlin
Journal:  Arch Gen Psychiatry       Date:  1983-04
View more
  1 in total

Review 1.  Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.

Authors:  Robert M Post; Terence A Ketter; Thomas Uhde; James C Ballenger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.